News /

Filtered:

Reviews (Remove filters)

Product launch - Human NGAL monomer-specific ELISA

BioPorto launches the first human NGAL monomer specific assay. 

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity, AKI treatment, Other
Date

Product launch - recombinant NGAL antigens

An expansion of BioPorto Diagnostics extensive NGAL portfolio with 6 new Recombinant NGAL Antigens 

Read more
Category
Research
Clinical Relevance
Other
Date

Bangert K (2012) ASN Kidney Week

The molecular forms of NGAL is a hot topic amongst NGAL researches these days.

Read more
Source
http://ngal.com/media/55006/ngal_monomer_poster_asn-kidney_week.pdf
Date

Huber W (2012) J CLI 36:10-12

Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.

To download as pdf please click here 

Read more
Source
http://www.cli-online.com/featured-articles/early-detection-of-acute-kidney-injury-in-sepsis-how-about-ngal/index.html
Date